Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127283801 | 12728380 | 1 | I | 20141031 | 20160902 | 20160909 | 20160909 | EXP | GB-ASTRAZENECA-2016SE94416 | ASTRAZENECA | 69.00 | YR | F | Y | 60.80000 | KG | 20160909 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127283801 | 12728380 | 1 | PS | ROSUVASTATIN. | ROSUVASTATIN | 1 | Oral | 40.0MG UNKNOWN | N | U | 21366 | 40 | MG | TABLET | |||||
| 127283801 | 12728380 | 2 | SS | ROSUVASTATIN. | ROSUVASTATIN | 1 | Oral | 10.0MG UNKNOWN | N | U | 21366 | 10 | MG | TABLET | |||||
| 127283801 | 12728380 | 3 | SS | EZETROL | EZETIMIBE | 1 | Oral | 40.0MG UNKNOWN | N | U | 0 | 40 | MG | ||||||
| 127283801 | 12728380 | 4 | SS | EZETROL | EZETIMIBE | 1 | Oral | 10.0MG UNKNOWN | N | U | 0 | 10 | MG | ||||||
| 127283801 | 12728380 | 5 | SS | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 40.0MG UNKNOWN | N | U | 0 | 40 | MG | ||||||
| 127283801 | 12728380 | 6 | SS | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 10.0MG UNKNOWN | N | U | 0 | 10 | MG | ||||||
| 127283801 | 12728380 | 7 | SS | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 40.0MG UNKNOWN | N | U | 0 | 40 | MG | ||||||
| 127283801 | 12728380 | 8 | SS | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 10.0MG UNKNOWN | N | U | 0 | 10 | MG | ||||||
| 127283801 | 12728380 | 9 | SS | CLOFIBRATE | CLOFIBRATE | 1 | Oral | 40.0MG UNKNOWN | N | U | 0 | 40 | MG | ||||||
| 127283801 | 12728380 | 10 | SS | CLOFIBRATE | CLOFIBRATE | 1 | Oral | 10.0MG UNKNOWN | N | U | 0 | 10 | MG | ||||||
| 127283801 | 12728380 | 11 | C | IBUPROFEN. | IBUPROFEN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127283801 | 12728380 | 1 | Blood cholesterol increased |
| 127283801 | 12728380 | 2 | Blood cholesterol increased |
| 127283801 | 12728380 | 3 | Blood cholesterol increased |
| 127283801 | 12728380 | 4 | Blood cholesterol increased |
| 127283801 | 12728380 | 5 | Blood cholesterol increased |
| 127283801 | 12728380 | 6 | Blood cholesterol increased |
| 127283801 | 12728380 | 7 | Blood cholesterol increased |
| 127283801 | 12728380 | 8 | Blood cholesterol increased |
| 127283801 | 12728380 | 9 | Blood cholesterol increased |
| 127283801 | 12728380 | 10 | Blood cholesterol increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127283801 | 12728380 | DS |
| 127283801 | 12728380 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127283801 | 12728380 | Arthropathy | |
| 127283801 | 12728380 | Pain | |
| 127283801 | 12728380 | Sleep disorder due to a general medical condition |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127283801 | 12728380 | 1 | 20141019 | 20160819 | 0 | |
| 127283801 | 12728380 | 2 | 20160819 | 0 | ||
| 127283801 | 12728380 | 3 | 20141019 | 20160819 | 0 | |
| 127283801 | 12728380 | 4 | 20160819 | 0 | ||
| 127283801 | 12728380 | 5 | 20141019 | 20160819 | 0 | |
| 127283801 | 12728380 | 6 | 20160819 | 0 | ||
| 127283801 | 12728380 | 7 | 20141019 | 20160819 | 0 | |
| 127283801 | 12728380 | 8 | 20160819 | 0 | ||
| 127283801 | 12728380 | 9 | 20141019 | 20160819 | 0 | |
| 127283801 | 12728380 | 10 | 20160819 | 0 |